SMAR Investors Have Opportunity to Lead Smartsheet Inc. Securities Fraud Lawsuit

Rosen Law Firm announced a securities class action for Smartsheet (SMAR) sellers covering June 1, 2024–Sept. 23, 2024, alleging inadequate disclosure around an unsolicited acquisition offer. The consortium’s bid increased from $56.25 (Jan. 24, 2024) to $56.50 (July 8 and reiterated Aug. 21) while Smartsheet reportedly repurchased shares below the offer price; the deal ultimately closed on Jan. 22, 2025 at $56.50/share. Lead-plaintiff motion deadline is Oct. 5, 2026, which may create modest headline risk but is not yet a certified class.

Analysis

This is mostly a post-close redistribution event, not a fresh fundamental shock. The cash consideration is already fixed, so the market-impactful question is who absorbs the legal bill and whether the narrative leaks into board behavior at other software names that are still using buybacks as a valuation support mechanism. In practice, the direct economic hit to the acquired company is usually modest and gets routed through D&O insurance, while the bigger effect is a small but real increase in governance risk premium for any mid-cap SaaS board that is both repurchasing stock and entertaining strategic interest.

The second-order effect is on capital allocation optics: repurchases that once signaled confidence can now be framed as evidence of selective disclosure risk, which may make management teams more reluctant to buy back stock aggressively into weakness. That matters most over 1-3 quarters for names where buybacks are a meaningful part of the equity story, and over 6-18 months it can slightly compress multiples for software companies trading on “cheap vs. peers” rather than durable growth.

Contrarian view: the street tends to overprice the litigation headline and underprice the fact that, after a deal closes, most of the economics are already spoken for. Unless discovery uncovers a broader disclosure pattern or triggers an SEC/derivative follow-on, this should remain a nuisance claim rather than a sector-level catalyst. The thesis is falsified if the case expands beyond a fee-and-settlement overhang into board-level remedies or if similar complaints start impairing buyback authorization behavior across the SaaS universe.

Key Decisions for Investors

• No direct trade in SMAR: treat as post-close legal noise, not a standalone alpha source; any recoverable value is likely trapped in the claims process rather than the public equity.
• Do not short software beta on this headline; the right read is governance risk, not a deterioration in recurring-revenue fundamentals.
• Set a 1-3 month watchlist on buyback-heavy SaaS names with strategic optionality (e.g., BOX, DOCN, ZUO, QTWO): if they trade on repurchase support rather than operating re-acceleration, expect a small valuation discount to persist.
• If you want a hedgeable expression, consider a small basket long D&O-insurer exposure (CB, HIG) against a short in litigation-sensitive mid-cap software on any sector squeeze; risk/reward is better as a relative-value hedge than an outright directional bet.
• Falsifier/alert: if there is a follow-on SEC or derivative action before the next earnings cycle, reassess for broader governance contagion; absent that, this is likely a low-conviction watch item.